Strong JM - Search Results

1

Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.

Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM. Anderson LW, et al. Among authors: strong jm. Clin Cancer Res. 1996 Sep;2(9):1481-7. Clin Cancer Res. 1996. PMID: 9816324 Clinical Trial.

2

Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood.

Anderson LW, Ludeman SM, Colvin OM, Grochow LB, Strong JM. Anderson LW, et al. Among authors: strong jm. J Chromatogr B Biomed Appl. 1995 May 19;667(2):247-57. doi: 10.1016/0378-4347(95)00036-i. J Chromatogr B Biomed Appl. 1995. PMID: 7663697 Free article.

3

Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices.

Parker RJ, Collins JM, Strong JM. Parker RJ, et al. Among authors: strong jm. Drug Metab Dispos. 1996 Nov;24(11):1167-73. Drug Metab Dispos. 1996. PMID: 8937848

4

In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices.

McNeilly PJ, Torchin CD, Anderson LW, Kapetanovic IM, Kupferberg HJ, Strong JM. McNeilly PJ, et al. Among authors: strong jm. Xenobiotica. 1997 May;27(5):431-41. doi: 10.1080/004982597240424. Xenobiotica. 1997. PMID: 9179986

5

Effect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: implications for clinical correlation.

Ludden LK, Ludden TM, Collins JM, Pentikis HS, Strong JM. Ludden LK, et al. Among authors: strong jm. J Pharmacol Exp Ther. 1997 Jul;282(1):391-6. J Pharmacol Exp Ther. 1997. PMID: 9223579

6

Murine and human in vivo penclomedine metabolism.

Hartman NR, O'Reilly S, Rowinsky EK, Collins JM, Strong JM. Hartman NR, et al. Among authors: strong jm. Clin Cancer Res. 1996 Jun;2(6):953-62. Clin Cancer Res. 1996. PMID: 9816256

7

Gas chromatographic-mass spectrometric method for routine monitoring of 5-fluorouracil in plasma of patients receiving low-level protracted infusions.

Anderson LW, Parker RJ, Collins JM, Ahlgren JD, Wilkinson D, Strong JM. Anderson LW, et al. Among authors: strong jm. J Chromatogr. 1992 Oct 23;581(2):195-201. doi: 10.1016/0378-4347(92)80272-r. J Chromatogr. 1992. PMID: 1452610

8

Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.

Strong JM, Collins JM, Lester C, Poplack DG. Strong JM, et al. Cancer Res. 1986 Dec;46(12 Pt 1):6101-4. Cancer Res. 1986. PMID: 3096555

9

The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.

Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM. Moody DE, et al. Among authors: strong jm. Drug Metab Dispos. 1997 Dec;25(12):1347-53. Drug Metab Dispos. 1997. PMID: 9394023

10

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.

Weaver JL, Contrera JF, Rosenzweig BA, Thompson KL, Faustino PJ, Strong JM, Ellison CD, Anderson LW, Prasanna HR, Long-Bradley PE, Lin KK, Zhang J, Sistare FD. Weaver JL, et al. Among authors: strong jm. Toxicol Pathol. 1998 Jul-Aug;26(4):532-40. doi: 10.1177/019262339802600409. Toxicol Pathol. 1998. PMID: 9715512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters